Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fran E Cook-Bolden

Showing results (11-20 of 35) with videos related to

Pageof 4
Sort By:
Journal of Drugs in Dermatology : JDD|January 26, 2019
Novel Tretinoin 0.05% Lotion for Once-Daily Treatment of Moderate-to-Severe Acne Vulgaris in a Hispanic PopulationFran E. Cook-Bolden, Susan H. Weinkle, Eric Guenin, et al.
Journal of Drugs in Dermatology : JDD|September 17, 2014
An aqueous gel fixed combination of clindamycin phosphate 1.2% and benzoyl peroxide 3.75% for the once-daily treatment of moderate to severe acne vulgarisDavid M Pariser, Phoebe Rich, Fran E Cook-Bolden, et al.
The Journal of Clinical and Aesthetic Dermatology|June 6, 2015
[Not Available]Firas George Hougeir, Fran E Cook-Bolden, David Rodriguez, et al.
Cutis|September 11, 2020
Tolerability of tretinoin lotion 0.05% for moderate to severe acne vulgaris: a post hoc analysis in a black populationNeal D Bhatia, William P Werschler, Fran E Cook-Bolden, et al.
Journal of the American Academy of Dermatology|January 25, 2002
Defining pseudofolliculitis barbae in 2001: a review of the literature and current trendsPatricia K Perry, Fran E Cook-Bolden, Zakia Rahman, et al.
Journal of Drugs in Dermatology : JDD|March 22, 2007
Safety and efficacy of desonide hydrogel 0.05% in pediatric subjects with atopic dermatitisAdelaide A Hebert, Fran E Cook-Bolden, Sarmistha Basu, et al.
American Journal of Clinical Dermatology|April 19, 2021
50 Years of Topical Retinoids for Acne: Evolution of TreatmentHilary Baldwin, Guy Webster, Linda Stein Gold, et al.
Journal of Drugs in Dermatology : JDD|August 27, 2020
Halobetasol Propionate Lotion 0.01% for Moderate-to-Severe Plaque Psoriasis: Pooled Analysis in Male and Female ParticipantsFran E Cook-Bolden, Adelaide A Hebert, Scott T Guenthner, et al.
Journal of Drugs in Dermatology : JDD|January 18, 2017
Results of a Phase 2, Randomized,Vehicle-Controlled Study Evaluating the Efficacy,Tolerability, and Safety of Daily or Twice Daily SB204 for the Treatment of Acne VulgarisLawrence F Eichenfield, Linda Stein Gold, Walter K Nahm, et al.
American Journal of Clinical Dermatology|November 9, 2021
Effects of Topical Retinoids on Acne and Post-inflammatory Hyperpigmentation in Patients with Skin of Color: A Clinical Review and Implications for PracticeValerie D Callender, Hilary Baldwin, Fran E Cook-Bolden, et al.
Pageof 4

Showing results (11-20 of 35) with videos related to

Sort By:
Pageof 4
Journal of Drugs in Dermatology : JDD|January 26, 2019
Novel Tretinoin 0.05% Lotion for Once-Daily Treatment of Moderate-to-Severe Acne Vulgaris in a Hispanic PopulationFran E. Cook-Bolden, Susan H. Weinkle, Eric Guenin, et al.
Journal of Drugs in Dermatology : JDD|September 17, 2014
An aqueous gel fixed combination of clindamycin phosphate 1.2% and benzoyl peroxide 3.75% for the once-daily treatment of moderate to severe acne vulgarisDavid M Pariser, Phoebe Rich, Fran E Cook-Bolden, et al.
The Journal of Clinical and Aesthetic Dermatology|June 6, 2015
[Not Available]Firas George Hougeir, Fran E Cook-Bolden, David Rodriguez, et al.
Cutis|September 11, 2020
Tolerability of tretinoin lotion 0.05% for moderate to severe acne vulgaris: a post hoc analysis in a black populationNeal D Bhatia, William P Werschler, Fran E Cook-Bolden, et al.
Journal of the American Academy of Dermatology|January 25, 2002
Defining pseudofolliculitis barbae in 2001: a review of the literature and current trendsPatricia K Perry, Fran E Cook-Bolden, Zakia Rahman, et al.
Journal of Drugs in Dermatology : JDD|March 22, 2007
Safety and efficacy of desonide hydrogel 0.05% in pediatric subjects with atopic dermatitisAdelaide A Hebert, Fran E Cook-Bolden, Sarmistha Basu, et al.
American Journal of Clinical Dermatology|April 19, 2021
50 Years of Topical Retinoids for Acne: Evolution of TreatmentHilary Baldwin, Guy Webster, Linda Stein Gold, et al.
Journal of Drugs in Dermatology : JDD|August 27, 2020
Halobetasol Propionate Lotion 0.01% for Moderate-to-Severe Plaque Psoriasis: Pooled Analysis in Male and Female ParticipantsFran E Cook-Bolden, Adelaide A Hebert, Scott T Guenthner, et al.
Journal of Drugs in Dermatology : JDD|January 18, 2017
Results of a Phase 2, Randomized,Vehicle-Controlled Study Evaluating the Efficacy,Tolerability, and Safety of Daily or Twice Daily SB204 for the Treatment of Acne VulgarisLawrence F Eichenfield, Linda Stein Gold, Walter K Nahm, et al.
American Journal of Clinical Dermatology|November 9, 2021
Effects of Topical Retinoids on Acne and Post-inflammatory Hyperpigmentation in Patients with Skin of Color: A Clinical Review and Implications for PracticeValerie D Callender, Hilary Baldwin, Fran E Cook-Bolden, et al.
Pageof 4